Jinq-May Chen

1.1k citations
10 papers · 884 indexed · h-index 9

Impact in

Papers in

    • Adenosine and Purinergic Signaling 1
    • Peptidase Inhibition and Analysis 5

Jinq-May Chen

10 papers receiving 869 citations

Peers

Jinq-May Chen
Comparison fields: 5 of 80
  • Cancer Research 223
  • Oncology 296
  • Biotechnology 87
  • Microbiology 56
  • Parasitology 48
Replace Pam M. Dando with:
Pam M. Dando United Kingdom
Motoki Tamai Japan
Mara Fortunato United Kingdom
Yonghwan Kim South Korea
Gholamreza Hassanzadeh Ghassabeh Belgium
P. Elaine Butler United Kingdom
Zala Jevnikar Slovenia
Kiran Kaur United States
Youngjun Kim South Korea
Preethi Jayanth Canada
Jinq-May Chen relative to Pam M. Dando United Kingdom Pam M. Dando's profile →
Citations per field
00.5×1.5×
Pam M. Dando · 1×
Citations per year

Countries citing papers authored by Jinq-May Chen

Since Specialization
Citations

This map shows the geographic impact of Jinq-May Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinq-May Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinq-May Chen more than expected).

Fields of papers citing papers by Jinq-May Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinq-May Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinq-May Chen. The network helps show where Jinq-May Chen may publish in the future.

Co-authors

The 12 scholars most cited alongside Jinq-May Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jinq-May Chen Line = papers co-authored together Jinq-May Chen links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 200185
2 200067
3 200016
4 1998189
5 19982
6 1998118
7 1997310
8 19959
9 198736
10 198552

About Jinq-May Chen

Jinq-May Chen is a scholar working on Physiology, Oncology, Microbiology, Cancer Research and Cellular and Molecular Neuroscience, having authored 10 papers that have together received 884 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (5 papers), Signaling Pathways in Disease (3 papers), Biochemical and Structural Characterization (2 papers), Protease and Inhibitor Mechanisms (2 papers), Neuropeptides and Animal Physiology (2 papers), Adenosine and Purinergic Signaling (1 paper), Chemical Synthesis and Analysis (1 paper) and Porphyrin Metabolism and Disorders (1 paper). The work is most often cited by research in Cancer Research (223 citations), Oncology (296 citations), Biotechnology (87 citations), Microbiology (56 citations) and Parasitology (48 citations). Jinq-May Chen has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include A. John Barrett, Richard Stevens, Neil D. Rawlings, Mara Fortunato, Pam M. Dando, M A Brown, Colin Watts, Eric W. Hewitt, Charles D. Little and Mano J. Thubrikar. Their work appears in journals such as Biochemical Journal, FEBS Letters, Experimental Cell Research, Atherosclerosis and Developmental Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026